Home / Companies / Cosmo Pharmaceuticals NV / 24 May 2024
Cosmo Pharmaceuticals NV: meeting of 24 May 2024
Votes reported on Form N-PX, item by item
22 Form N-PX filers reported votes at the Cosmo Pharmaceuticals NV meeting of 24 May 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
7 nominees; 42.9% of reported votes for; 12 filers withheld from or voted against at least one nominee.
224 vote records from 22 filers. 10 of the 16 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
SHAREHOLDER RIGHTS AND DEFENSESIssuer
SHAREHOLDER RIGHTS AND DEFENSES: management items
Management items in this category are shown together; filers word and number them differently.
28 vote records from 18 filers. 15 of the 15 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
132 vote records from 22 filers. 5 of the 16 filers that marked the item either way voted against management. 6 filers reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
3 vote records from 3 filers. No filer marked a management recommendation, so no against-management figure is reported. 3 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
18 vote records from 6 filers. No filer marked a management recommendation, so no against-management figure is reported. 6 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | Against * |
| Dimensional | Against * |
| State Street and SPDR | Against * |
| American Century | Against * |
| Charles Schwab | For |
| Nuveen and TIAA | Against * |
| John Hancock and Manulife | Split or no vote |
| Lincoln Financial | Split or no vote |
| Brighthouse Funds | Split or no vote |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Cosmo Pharmaceuticals NV meeting?
22 Form N-PX filers reported votes at the meeting of 24 May 2024. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Cosmo Pharmaceuticals NV on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Cosmo Pharmaceuticals NV
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Cosmo Pharmaceuticals NV with a meeting date within three days of 24 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.